Steinbach F, Stöckle M, Kiewel R, Störkel S, Stein R, Hohenfellner R
Department of Urology, Mainz Medical School, FRG.
Eur Urol. 1993;24(2):279-85.
In 133 cases of patients with renal cell carcinoma which infiltrated locally into the renal fatty tissue (stage pT3a, TNM classification of 1987), the prognostic potential of the following parameters was investigated: symptoms, patient's age at the time of operation, tumor size and localization, grade of malignancy, cell type, growth pattern, and prognostic score according to Störkel et al. [Eur Urol 1990;18(suppl 2):36]. Additionally, automated image analysis DNA cytometry was performed on 110/133 carcinomas. After an average observation period of 3.6 years (maximum 10.1 years), 59 (44.4%) of the patients died of their tumors. The cause-specific 5- and 10-year survival rates were 51.3 and 29.1%, respectively. Statistically significant differences (p < 0.05) within the individual parameters were found only for the grade of malignancy and the corresponding prognostic score. Using DNA cytometry, 13 types of renal cell carcinoma were differentiated; 90% of the tumors contained aneuploid cells. Significant differences between these relative to prognosis did not exist. In the case of locally advanced renal cell carcinoma, the DNA histogram does not seem to be superior to conventional prognostic criteria.
在133例局部浸润肾脂肪组织的肾细胞癌患者(1987年TNM分期为pT3a期)中,研究了以下参数的预后潜力:症状、手术时患者年龄、肿瘤大小和位置、恶性程度分级、细胞类型、生长模式以及根据施托克尔等人的标准计算的预后评分[《欧洲泌尿外科杂志》1990年;18(增刊2):36]。此外,对133例中的110例癌组织进行了自动图像分析DNA细胞计量术检测。平均观察期为3.6年(最长10.1年)后,59例(44.4%)患者死于肿瘤。特定病因的5年和10年生存率分别为51.3%和29.1%。仅在恶性程度分级和相应的预后评分这两个个体参数中发现了具有统计学意义的差异(p<0.05)。通过DNA细胞计量术,区分出13种肾细胞癌类型;90%的肿瘤含有非整倍体细胞。它们在预后方面不存在显著差异。对于局部进展性肾细胞癌,DNA直方图似乎并不优于传统的预后标准。